Apricus Biosciences (APRI) Expands Senior Management Team, Appointing Neil C. Morton As Vice President, Business Development
3/20/2014 9:28:15 AM
SAN DIEGO, March 20, 2014 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a pharmaceutical company focusing on the development and commercialization of novel therapeutics for men's and women's health, today announced the appointment of Neil C. Morton as Vice President of Business Development. Mr. Morton brings to Apricus a successful track record in business development in specialty pharmaceuticals, most recently serving as the Executive Director of Business Development at Auxilium Pharmaceuticals Inc., where he successfully led their efforts to build a pipeline of men's health products to include in-licensing of Stendra™ from Vivus, Inc. and the acquisition of Actient Pharmaceuticals. He will report to Richard Pascoe, Apricus' Chief Executive Officer, and his appointment is effective immediately. Edward Cox, who previously served in this position, will transition to the newly created role of Vice President of Commercial Development where he will primarily focus on supporting the launch of Vitaros® in Europe and Canada.
Help employers find you! Check out all the jobs and post your resume.
comments powered by